Diabetes News

SAN DIEGO — Patients with type 2 diabetes and chronic kidney disease who received linagliptin showed a slowed progression of albuminuria without changing eGFR or other kidney outcomes, according to data presented at ASN Kidney Week.

SAN DIEGO — Patients with diabetic chronic kidney disease who used metformin showed all-cause mortality and ESRD progression benefits, according to data presented at ASN Kidney Week 2018.

BOSTON — Among the variety of GLP-1 receptor agonists approved for treatment of type 2 diabetes, each has traits that benefit some users more than others, allowing many adults with diabetes to take advantage of this medication class, according to a presenter at the Cardiometabolic Health Congress.

The Mediterranean diet was linked to prolonged survival in two different studies spanning multiple age groups, according to findings recently published in the British Journal of Nutrition.

Children with type 1 diabetes, vitamin B12 deficiency and nephropathy assigned to 12 weeks of vitamin B supplementation experienced improvements in markers of renal disease and inflammation vs. those receiving usual care, suggesting the intervention may have a protective effect, according to findings presented at the European Society for Paediatric Endocrinology annual meeting.

Patients with undiagnosed hypertension typically had no other CVD or diabetes, according to findings recently published in Family Practice.

Adults with type 2 diabetes who switched from other DPP-IV inhibitors to teneligliptin for 24 weeks had decreased plasma DPP-IV activity, which was associated with a reduction in albuminuria, but they had no change in glucose levels, according to data from a single-arm, open-label, observational study published in the Journal of Diabetes Investigation.

WHO released recommendations regarding which medicines should be used for treatment intensification in adult patients with type 2 diabetes as well as the use of analogue or human insulin in type 1 and 2 diabetes.

From 1999 to 2016, all-cause mortality among adults aged between 25 years and 64 years in many different ethnic groups in the United States increased while life expectancy in the United States plateaued from 2010 to 2016, according to two studies published in BMJ.

A primary care physician’s lack of education on insulin use was one of the barriers to optimal use of insulin among patients with type 2 diabetes, according to data recently published in BMC Family Practice.